HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma
Abstract Background Heart development protein with EGF‐like domains 1 (HEG1), generally related to angiogenesis and embryonic development, was reported to participate in the occurrence and progression of some tumors recently. However, the role of HEG1 in lung adenocarcinoma (LUAD) is unclear. Patien...
Saved in:
| Main Authors: | Xin Zou, Yue Zhang, Ning Wang, Jie Shi, Qinghai Li, Wanming Hao, Wenjing Zhu, Wei Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5081 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of HEG1 and Claudin-4 Immunohistochemistry in the Differential Diagnosis of Lung Adenocarcinoma from Malignant Mesothelioma in Pleural Effusion Cytology
by: Aziza E. ABDELRAHMAN, et al.
Published: (2025-05-01) -
Aberrant expression of MRAS and HEG1 as the biomarkers for osimertinib resistance in LUAD
by: Mingxin Liu, et al.
Published: (2024-11-01) -
Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma
by: Dawei Sun, et al.
Published: (2025-04-01) -
SPC25 as a prognostic and immune-related biomarker in lung adenocarcinoma
by: Pan Liu, et al.
Published: (2025-07-01) -
UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma
by: Haofeng Yin, et al.
Published: (2025-08-01)